Rigorous Testing, No Exceptions: As a family business, we keep costs low and pass the savings directly to you
patient-specific Rx required Oklahoma Medicaid coverage / Not currently covered for either indication Typical first-visit-to-shipment timeline / 3 to 10 business days via telehealth Starting dose / 0.6 mg subcutaneously once daily for one week Weight-management dose target / 3.0 mg once daily (Saxenda) Type 2 diabetes dose target / 1.2 mg or 1.8 mg once daily (Victoza) Labs typically required before starting / Fasting glucose, HbA1c, thyroid panel, comprehensive metabolic panel Prescribers in Oklahoma / MD, DO, NP, PA all legally authorized What liraglutide is and why Oklahoma patients are seeking it Liraglutide is an injectable GLP-1 receptor agonist that mimics endogenous glucagon-like peptide-1 to reduce appetite, slow gastric emptying, and improve glycemic control
For people with metabolic syndrome or multiple cardiovascular risk factors, this broader metabolic improvement is potentially more important than the weight loss itself
Common side effects include nausea, diarrhea, constipation, and decreased appetite
For more detail on what this adjustment period can look like, see our article on GLP-1 side effects
Retrieved from Papakonstantinou, I., Tsioufis, K., & Katsi, V